The potential role of GLP-1 receptor agonists in substance use disorders a systematic review
Westhovens R, Taylor PC, Alten R, Pavlova D, Enrquez-Sosa F, Mazur M, Greenwald M, Van Der Aa A, Vanhoutte F, Tasset C, Harrison P (2017) Filgotinib (GLPG0634/GS-6034), an oral JAK1 selective inhibitor, is effective in combination with methotrexate (MTX) in patients with active rheumatoid arthritis and insufficient response to MTX: results from a randomised, dose-finding study (DARWIN 1)
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have garnered recognition as potentially revolutionary therapeutic modalities for MASLD/MASH management, offering multifaceted benefits extending beyond glycemic regulation
Arterioscler Thromb Vasc Biol (2015) 35(3):48591